Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Hoefle

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|January 1, 1990
Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazolesD R Sliskovic, B D Roth, M W Wilson, et al.
Journal of Medicinal Chemistry|February 1, 1975
Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanolsM L Hoefle, S G Hastings, R F Meyer, et al.
Journal of Medicinal Chemistry|January 1, 1990
Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleusB D Roth, D F Ortwine, M L Hoefle, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of cis-2,6-dimethyl-alpha,alpha-diaryl-1-piperidinebutanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Medicinal Chemistry|November 1, 1982
Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portionR G Almquist, J Crase, C Jennings-White, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of alpha-[(diarylmethoxy)methyl]-1-piperidineethanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Medicinal Chemistry|January 1, 1981
Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acidsS Klutchko, M L Hoefle, R D Smith, et al.
Journal of Medicinal Chemistry|October 1, 1986
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl typesS Klutchko, C J Blankley, R W Fleming, et al.
Journal of Medicinal Chemistry|June 1, 1987
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acidsC J Blankley, J S Kaltenbronn, D E DeJohn, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|January 1, 1990
Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazolesD R Sliskovic, B D Roth, M W Wilson, et al.
Journal of Medicinal Chemistry|February 1, 1975
Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanolsM L Hoefle, S G Hastings, R F Meyer, et al.
Journal of Medicinal Chemistry|January 1, 1990
Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleusB D Roth, D F Ortwine, M L Hoefle, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of cis-2,6-dimethyl-alpha,alpha-diaryl-1-piperidinebutanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Medicinal Chemistry|November 1, 1982
Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portionR G Almquist, J Crase, C Jennings-White, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of alpha-[(diarylmethoxy)methyl]-1-piperidineethanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Medicinal Chemistry|January 1, 1981
Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acidsS Klutchko, M L Hoefle, R D Smith, et al.
Journal of Medicinal Chemistry|October 1, 1986
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl typesS Klutchko, C J Blankley, R W Fleming, et al.
Journal of Medicinal Chemistry|June 1, 1987
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acidsC J Blankley, J S Kaltenbronn, D E DeJohn, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
Pageof 2